The antitumor effect of the Toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant

Cancer Immunology, Immunotherapy

Volumn 62, Issue 2, 2013, Pages 237-244

  Huang, Yu Kun ^a   Zheng, Zhi ^b   Cheng, Chun Xia ^b   Wang, Lu Ying ^b   Li, Yue Ran ^b   Qiu, Fu ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Immunoadjuvant; Natural killer cells; Polyinosinic polycytidylic acid; Toll like receptor; Tumor immunity

Indexed keywords

BETA INTERFERON; I KAPPA B ALPHA; IMMUNOLOGICAL ADJUVANT; MESSENGER RNA; MONOCLONAL ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 3;

ARTICLE; BIOLOGICAL ACTIVITY; CELL ACTIVITY; CELL KILLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TOLL LIKE RECEPTOR 3 GENE; TUMOR IMMUNITY;

ADJUVANTS, IMMUNOLOGIC; ANTIBODIES, NEUTRALIZING; CARCINOMA; CELL LINE; CELLS, CULTURED; FEMALE; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; INTERFERON INDUCERS; INTERFERON-BETA; KILLER CELLS, NATURAL; LIGANDS; POLY I-C; TOLL-LIKE RECEPTOR 3; UTERINE CERVICAL NEOPLASMS;

EID: 84874116245     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1328-z     Document Type: Article

References (23)

1. Sepulveda FE, Maschalidi S, Colisson R, Heslop L, Ghirelli C, Sakka E, Lennon-Dumenil AM, Amigorena S, Cabanie L, Manoury B (2009) Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31:737-748
2. Marta M (2009) Toll-like receptors in multiple sclerosis mouse experimental models. Ann N Y Acad Sci 1173:458-462
3. Seya T, Akazawa T, Uehori J, Matsumoto M, Azuma I, Toyoshima K (2003) Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer. Anticancer Res 23:4369-4376
4. Subleski JJ, Wiltrout RH, Weiss JM (2009) Application of tissue-specific NK and NKT cell activity for tumor immunotherapy. J Autoimmun 33:275-281
5. Lagadari M, Truta-Feles K, Lehmann K, Berod L, Ziemer M, Idzko M, Barz D, Kamradt T, Maghazachi AA, Norgauer J (2009) Lysophosphatidic acid inhibits the cytotoxic activity of NK cells: involvement of Gs protein-mediated signaling. Int Immunol 21:667-677
6. Xiong Y, Qiu F, Piao W, Song C, Wahl LM, Medvedev AE (2011) Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression. J Biol Chem 286:7905-7916
7. Huang YK, Fan XG, Qiu F, Wang ZM (2011) Genomics of hepatitis B virus-related hepatocellular carcinoma and adjacent noncancerous tissues with cDNA microarray. Chin Med J (Engl) 124:2057-2064
8. Weiss RA (2008) On viruses, discovery, and recognition. Cell 135:983-986
9. Cui Z, Qiu F (2006) Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model. Cancer Immunol Immunother 55:1267-1279
10. Qiu F, Cui Z (2007) CD4+ T helper cell response is required for memory in CD8+ T lymphocytes induced by a poly(I:C)-adjuvanted MHC I-restricted peptide epitope. J Immunother 30:180-189
11. Qiu F, Maniar A, Diaz MQ, Chapoval AI, Medvedev AE (2011) Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors. Innate Immun 17:375-387
12. Schmidt KN, Leung B, Kwong M, Zarember KA, Satyal S, Navas TA, Wang F, Godowski PJ (2004) APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 172:138-143
13. Fujita Y, Mihara T, Okazaki T, Shitanaka M, Kushino R, Ikeda C, Negishi H, Liu Z, Richards JS, Shimada M (2011) Toll-like receptors (TLR) 2 and 4 on human sperm recognize bacterial endotoxins and mediate apoptosis. Hum Reprod 26:2799-2806
14. Hou B, Reizis B, DeFranco AL (2008) Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity 29:272-282
15. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738
16. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T (2002) Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293:1364-1369
17. Raghuraman G, Geng Y, Wang CR (2006) IFN-beta-mediated up-regulation of CD1d in bacteria-infected APCs. J Immunol 177:7841-7848
18. Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, Benvenisty N (2002) Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 99:9864-9869
19. Li Q, Kawamura K, Okamoto S, Fujie H, Numasaki M, Namba M, Nagata M, Shimada H, Kobayashi H, Tagawa M (2011) Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-lambda genes produced anti-tumour effects. Br J Cancer 105:1302-1312
20. Dauphinee SM, Voelcker V, Tebaykina Z, Wong F, Karsan A (2011) Heterotrimeric Gi/Go proteins modulate endothelial TLR signaling independent of the MyD88-dependent pathway. Am J Physiol Heart Circ Physiol 301:H2246-H2253
21. Chun CD, Liles WC, Frevert CW, Glenny RW, Altemeier WA (2010) Mechanical ventilation modulates Toll-like receptor-3-induced lung inflammation via a MyD88-dependent, TLR4-independent pathway: a controlled animal study. BMC Pulm Med 10:57
22. Siednienko J, Halle A, Nagpal K, Golenbock DT, Miggin SM (2010) TLR3-mediated IFN-beta gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like. Eur J Immunol 40:3150-3160
23. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L, Moretta A (2004) CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101:10116-10121